Sterile Injectable Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 285

To learn more about this report, request a free sample copy

Sterile Injectable Market Overview

An overview of conceptual frameworks, analytical approaches of the sterile injectable market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Sterile injectable market is expected to grow with significant rate in the near future.

In 2020, global sterile injectables market was valued at US$ 398.6 Bn and expected to grow significantly at a CAGR of 7.4% over the forecast period.

Sterile Injectable Introduction

Sterile injectable drugs are antiseptic, parenteral arrangements consisting of one more Active Pharmaceutical Ingredient (API) designed for administration into the body. These arrangements are administered by infusion, injection, or implantation in the body with help of a syringe, needle, or implantable equipment. Basically, the generic sterile injectable attributes to biologics that serve its utility for the treatment of several different drugs and have the common active ingredients to that of the branded translation of it, however, the dormant elements of the drugs can be different. 

In the present-day world, the field of life sciences has progressively drifted its attention to the therapeutic divisions such as oncology, and thus, biologics have also become a bigger element of the pharmaceutical industry’s development pipeline, which fuels the growth of the sterile injectable market.

Moreover, the novel drug delivery systems that offer directed therapeutics are attaining eminence. Attributing to which, the sterile injectable is expected to observe high demand in the global market, therefore leading to brisk growth in the sterile injectable technologies and formulations market.

Sterility means the complete absence of any viable microorganism in a drug product. The specification of sterility is unchanging and is independent of the kind of manufacturing process: sterilization of the final product in its container closure system or aseptic manufacturing.

There are various sterile Injectable products that are available in two forms such as large and small volumes. The large volumes of the sterile products mainly include the infusions that are transfused in the subject’s body for various nutrients and other required salts. The small sterile products include parenteral products, eye, ear, and nasal drops. The sterile water for injection mainly offers life to the drugs in powder form that are administered into the body for the treatment of any ailment.

 

sterile injectables market report

 

Sterile Injectable Market Dynamics

The rapid need for treatment and attaining total bioavailability the parenteral drugs or microbiological drugs are being the first choice of the healthcare professional as it gives the immediate effect of in the body with a specific and targeted approach.

Due to the enormous increase in the number of emergency situations, there has been an increasing demand for more accurate as well as a rapid way of action to save lives.

Along with the increase in healthcare facilities and increase in research and development activity in the field of microbiology the awareness of the positive effects of sterile Injectable has been increased that is expected to support the rise in traction in Sterile Injectable market in the near future.

One of the major factors that are projected to propel the growth of the global sterile injectable market in the forthcoming years is the growing prevalence of chronic and acute diseases among the population across the globe owing to numerous factors.

In addition to that, there is a huge upsurge in the investments in the research and development activities by the key market players, giant life sciences firms, as well as several governments across the world which is also acting as a major driver that is projected to propel the growth of the global sterile injectable market in the near future. However, discontinuance of products and huge operational costs are few restraining factors that may hold back the growth of the global sterile injectable market during the forecast period.

Nevertheless, the increasing new drug delivery systems and growing launches of new drugs in present times is also estimated to positively fuel the growth of the global sterile injectable market in the upcoming future.

Apart from that, the swift approvals from the FDA for sterile oncology injectable along with minimized approval times for novel drug development with regard to cancer care is assisting key manufacturers of the global market to further propel the drug supplies.

Such factors are further expected to augment the growth of the global sterile injectable market in the upcoming years.

Sterile Injectable Market Key Players

Some of the key participating players in the Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., JHP Pharmaceuticals, Pfizer Inc., Fresenius Kabi Ag, CordenPharma, and Hikma Pharmaceuticals PLC

Sterile Injectable Market Segmentation

The global sterile Injectable market is segmented on the basis of packaging type, molecule type, drug type, therapeutic application, route of administration, distribution channel and region.

By Packaging Type

Pre-filled Syringes

Vials

Ampoules

By Molecule Type

Large Molecule

Small Molecule

By Drug Type

Monoclonal Antibodies (mAbs)

Cytokines

Insulin

Peptide Hormones

Immunoglobulins

Blood Factors

Peptide Antibiotics

Others

By Therapeutic Application

Cancer

Metabolic Diseases

Cardiovascular Diseases

Central Nervous Systems Disorders

Infectious Disorders

Musculoskeletal Disorders

Others

By Route of Administration

Subcutaneous (SC)

Intravenous (IV)

Intramuscular (IM)

Others

By Distribution Channel

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

The global sterile injectable market is expected to increase at a significant CAGR over the forecast period owing to the increasing chronic diseases, geriatric population, and increase in trend for immediate relief across the healthcare receivers.

Increasing expenditure in microbiological drug discoveries in the healthcare industry is also one of the major factors, which is expected to increase the demand for sterile Injectable market globally over the forecast period. The increase in the adoption of sterile Injectable by the various healthcare professionals may enhance the demand for the sterile Injectable product.

Sterile Injectable Market Regional Analysis

On the basis of region, the global sterile injectable market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America Sterile Injectable market is expected to be the most dominating market throughout the forecast period. Availability of key players and increasing healthcare expenditure in the region are some of the revenue-boosting factors.


To learn more about this report, request a free sample copy


1.    Global Sterile Injectables Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Sterile Injectables Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Sterile Injectables Market Snapshot

2.4.    Global Sterile Injectables Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Sterile Injectables Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Sterile Injectables Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Small Molecules

3.2.2.    Large Molecules

3.3.     Global Sterile Injectables Market Attractiveness Index, By Product Type

4.    Global Sterile Injectables Market, By Drug Type

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Drug Type

4.1.2.    BPS Analysis, By Drug Type

4.2.    Market Revenue (US$Mn) Forecast, By Drug Type

4.2.1.    Monoclonal Antibodies (mAbs)

4.2.2.    Cytokines

4.2.3.    Insulin

4.2.4.    Peptide Hormones

4.2.5.    Vaccines

4.2.6.    Immunoglobulin

4.2.7.    Blood Factors

4.2.8.    Peptide Antibiotics

4.2.9.    Others

4.3.     Global Sterile Injectables Market Attractiveness Index, By Drug Type

5.    Global Sterile Injectables Market, By Therapeutic Application

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Therapeutic Application

5.1.2.    BPS Analysis, By Therapeutic Application

5.2.    Market Revenue (US$Mn) Forecast, By Therapeutic Application

5.2.1.    Cancer

5.2.2.    Diabetes

5.2.3.    Cardiovascular Diseases

5.2.4.    Central Nervous Systems

5.2.5.    Infectious Disorders

5.2.6.    Musculoskeletal

5.2.7.    Others

5.3.     Global Sterile Injectables Market Attractiveness Index, By Therapeutic Application

6.    Global Sterile Injectables Market, By End User

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By End User

6.1.2.    BPS Analysis, By End User

6.2.    Market Revenue (US$Mn) Forecast, By End User

6.2.1.    Hospitals

6.2.2.    Drug Stores

6.2.3.    Pharmacies

6.2.4.    Online Pharmacies

6.3.     Global Sterile Injectables Market Attractiveness Index, By End User

7.    Global Sterile Injectables Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$Mn) Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East

7.2.6.    Africa

7.3.    Global Sterile Injectables Market Attractiveness Index, By Region

8.    North America Sterile Injectables Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) Forecast, By Country

8.2.1.    U.S. Sterile Injectables Market

8.2.2.    Canada Sterile Injectables Market

8.3.    North America Sterile Injectables Market, By Product Type

8.3.1.    Small Molecules

8.3.2.    Large Molecules

8.4.    North America Sterile Injectables Market, By Drug Type

8.4.1.    Monoclonal Antibodies (mAbs)

8.4.2.    Cytokines

8.4.3.    Insulin

8.4.4.    Peptide Hormones

8.4.5.    Vaccines

8.4.6.    Immunoglobulin

8.4.7.    Blood Factors

8.4.8.    Peptide Antibiotics

8.4.9.    Others

8.5.    North America Sterile Injectables Market, By Therapeutic Application

8.5.1.    Cancer

8.5.2.    Diabetes

8.5.3.    Cardiovascular Diseases

8.5.4.    Central Nervous Systems

8.5.5.    Infectious Disorders

8.5.6.    Musculoskeletal

8.5.7.    Others

8.6.    North America Sterile Injectables Market, By End User

8.6.1.    Hospitals

8.6.2.    Drug Stores

8.6.3.    Pharmacies

8.6.4.    Online Pharmacies

8.7.    North America Sterile Injectables Market Attractiveness Index

8.7.1.    By Country

8.7.2.    By Product Type

8.7.3.    By Drug Type

8.7.4.    By Therapeutic Application

8.7.5.    By End User

9.    Latin America Sterile Injectables Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    Brazil Sterile Injectables Market

9.2.2.    Mexico Sterile Injectables Market

9.2.3.    Argentina Sterile Injectables Market

9.2.4.    Rest of Latin America Sterile Injectables Market

9.3.    Latin America Sterile Injectables Market, By Product Type

9.3.1.    Small Molecules

9.3.2.    Large Molecules

9.4.    Latin America Sterile Injectables Market, By Drug Type

9.4.1.    Monoclonal Antibodies (mAbs)

9.4.2.    Cytokines

9.4.3.    Insulin

9.4.4.    Peptide Hormones

9.4.5.    Vaccines

9.4.6.    Immunoglobulin

9.4.7.    Blood Factors

9.4.8.    Peptide Antibiotics

9.4.9.    Others

9.5.    Latin America Sterile Injectables Market, By Therapeutic Application

9.5.1.    Cancer

9.5.2.    Diabetes

9.5.3.    Cardiovascular Diseases

9.5.4.    Central Nervous Systems

9.5.5.    Infectious Disorders

9.5.6.    Musculoskeletal

9.5.7.    Others

9.6.    Latin America Sterile Injectables Market, By End User

9.6.1.    Hospitals

9.6.2.    Drug Stores

9.6.3.    Pharmacies

9.6.4.    Online Pharmacies

9.7.    Latin America Sterile Injectables Market Attractiveness Index

9.7.1.    By Country

9.7.2.    By Product Type

9.7.3.    By Drug Type

9.7.4.    By Therapeutic Application

9.7.5.    By End User

10.    Europe Sterile Injectables Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    U.K. Sterile Injectables Market

10.2.2.    Germany Sterile Injectables Market

10.2.3.    Italy Sterile Injectables Market

10.2.4.    France Sterile Injectables Market

10.2.5.    Spain Sterile Injectables Market

10.2.6.    Russia Sterile Injectables Market

10.2.7.    Poland Sterile Injectables Market

10.2.8.    BENELUX Sterile Injectables Market

10.2.9.    NORDIC Sterile Injectables Market

10.2.10.    Rest of Europe Sterile Injectables Market

10.3.    Europe Sterile Injectables Market, By Product Type

10.3.1.    Small Molecules

10.3.2.    Large Molecules

10.4.    Europe Sterile Injectables Market, By Drug Type

10.4.1.    Monoclonal Antibodies (mAbs)

10.4.2.    Cytokines

10.4.3.    Insulin

10.4.4.    Peptide Hormones

10.4.5.    Vaccines

10.4.6.    Immunoglobulin

10.4.7.    Blood Factors

10.4.8.    Peptide Antibiotics

10.4.9.    Others

10.5.    Europe Sterile Injectables Market, By Therapeutic Application

10.5.1.    Cancer

10.5.2.    Diabetes

10.5.3.    Cardiovascular Diseases

10.5.4.    Central Nervous Systems

10.5.5.    Infectious Disorders

10.5.6.    Musculoskeletal

10.5.7.    Others

10.6.    Europe Sterile Injectables Market, By End User

10.6.1.    Hospitals

10.6.2.    Drug Stores

10.6.3.    Pharmacies

10.6.4.    Online Pharmacies

10.7.    Europe Sterile Injectables Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Product Type

10.7.3.    By Drug Type

10.7.4.    By Therapeutic Application

10.7.5.    By End User

11.    Asia Pacific Sterile Injectables Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    China Sterile Injectables Market

11.2.2.    India Sterile Injectables Market

11.2.3.    Japan Sterile Injectables Market

11.2.4.    Australia and New Zealand Sterile Injectables Market

11.2.5.    South Korea Sterile Injectables Market

11.2.6.    ASEAN Sterile Injectables Market

11.2.7.    Rest of Asia Pacific Sterile Injectables Market

11.3.    Asia Pacific Sterile Injectables Market, By Product Type

11.3.1.    Small Molecules

11.3.2.    Large Molecules

11.4.    Asia Pacific Sterile Injectables Market, By Drug Type

11.4.1.    Monoclonal Antibodies (mAbs)

11.4.2.    Cytokines

11.4.3.    Insulin

11.4.4.    Peptide Hormones

11.4.5.    Vaccines

11.4.6.    Immunoglobulin

11.4.7.    Blood Factors

11.4.8.    Peptide Antibiotics

11.4.9.    Others

11.5.    Asia Pacific Sterile Injectables Market, By Therapeutic Application

11.5.1.    Cancer

11.5.2.    Diabetes

11.5.3.    Cardiovascular Diseases

11.5.4.    Central Nervous Systems

11.5.5.    Infectious Disorders

11.5.6.    Musculoskeletal

11.5.7.    Others

11.6.    Asia Pacific Sterile Injectables Market, By End User

11.6.1.    Hospitals

11.6.2.    Drug Stores

11.6.3.    Pharmacies

11.6.4.    Online Pharmacies

11.7.    Asia Pacific Sterile Injectables Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Product Type

11.7.3.    By Drug Type

11.7.4.    By Therapeutic Application

11.7.5.    By End User

12.    Middle East Sterile Injectables Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    GCC Countries Sterile Injectables Market

12.2.2.    Israel Sterile Injectables Market

12.2.3.    Oman Sterile Injectables Market

12.2.4.    Rest of Middle East Sterile Injectables Market

12.3.    Middle East Sterile Injectables Market, By Product Type

12.3.1.    Small Molecules

12.3.2.    Large Molecules

12.4.    Middle East Sterile Injectables Market, By Drug Type

12.4.1.    Monoclonal Antibodies (mAbs)

12.4.2.    Cytokines

12.4.3.    Insulin

12.4.4.    Peptide Hormones

12.4.5.    Vaccines

12.4.6.    Immunoglobulin

12.4.7.    Blood Factors

12.4.8.    Peptide Antibiotics

12.4.9.    Others

12.5.    Middle East Sterile Injectables Market, By Therapeutic Application

12.5.1.    Cancer

12.5.2.    Diabetes

12.5.3.    Cardiovascular Diseases

12.5.4.    Central Nervous Systems

12.5.5.    Infectious Disorders

12.5.6.    Musculoskeletal

12.5.7.    Others

12.6.    Middle East Sterile Injectables Market, By End User

12.6.1.    Hospitals

12.6.2.    Drug Stores

12.6.3.    Pharmacies

12.6.4.    Online Pharmacies

12.7.    Middle East Sterile Injectables Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Product Type

12.7.3.    By Drug Type

12.7.4.    By Therapeutic Application

12.7.5.    By End User

13.    Africa Sterile Injectables Market, By Region

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    South Africa Sterile Injectables Market

13.2.2.    Egypt Sterile Injectables Market

13.2.3.    North Africa Sterile Injectables Market

13.2.4.    Rest of Africa Sterile Injectables Market

13.3.    Africa Sterile Injectables Market, By Product Type

13.3.1.    Small Molecules

13.3.2.    Large Molecules

13.4.    Africa Sterile Injectables Market, By Drug Type

13.4.1.    Monoclonal Antibodies (mAbs)

13.4.2.    Cytokines

13.4.3.    Insulin

13.4.4.    Peptide Hormones

13.4.5.    Vaccines

13.4.6.    Immunoglobulin

13.4.7.    Blood Factors

13.4.8.    Peptide Antibiotics

13.4.9.    Others

13.5.    Africa Sterile Injectables Market, By Therapeutic Application

13.5.1.    Cancer

13.5.2.    Diabetes

13.5.3.    Cardiovascular Diseases

13.5.4.    Central Nervous Systems

13.5.5.    Infectious Disorders

13.5.6.    Musculoskeletal

13.5.7.    Others

13.6.    Africa Sterile Injectables Market, By End User

13.6.1.    Hospitals

13.6.2.    Drug Stores

13.6.3.    Pharmacies

13.6.4.    Online Pharmacies

13.7.    Africa Sterile Injectables Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Product Type

13.7.3.    By Drug Type

13.7.4.    By Therapeutic Application

13.7.5.    By End User

14.    Recommendation

14.1.    Market Strategy

15.    Competitive Landscape

15.1.    Competition Dashboard

15.2.    List and Company Overview of Global Key Players

15.3.    Company Profiles

15.3.1.    Baxter International Inc.

15.3.1.1.    Company Overview

15.3.1.2.    Financial Overview

15.3.1.3.    Product Portfolio

15.3.1.4.    Key Developments

15.3.1.5.    Business Strategies

15.3.2.    Pfizer In.

15.3.3.    GlaxoSmithkline Plc

15.3.4.    Sanofi

15.3.5.    AstraZeneca

15.3.6.    Gilead Sciences Inc.

15.3.7.    Merck & Co., Inc.

15.3.8.     Novartis AG

15.3.9.    Johnson & Johnson

15.3.10.    Nova Nordisk A/S

15.3.11.    Lupin Limited

16.    Acronyms

Select License Type

Frequently Asked Questions

In 2020, global sterile injectables market was valued at US$ 398.6 Bn and expected to grow significantly at a CAGR of 7.4% over the forecast period.

Due to the enormous increase in the number of emergency situations, Along with the increase in healthcare facilities and increase in research and development activity in the field of microbiology. The rapid need for treatment and attaining total bioavailability the parenteral drugs or microbiological drugs are some of the key factors driving the growth of market

The global sterile Injectable market is segmented on the basis of packaging type, molecule type, drug type, therapeutic application, route of administration, distribution channel and region

Sterile Injectable market is mainly dominated by Baxter International Inc., Pfizer, GlaxoSmithkline Plc., Sanofi, AstraZeneca, Gilead Sciences Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Nova Nordisk A/S, and Lupin Limited are the key participating players in the market



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK